glp-1 hub Store GLP‑1 Hub — GLP-1 Collective

cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East asians

First-line inavolisib/placebo + palbociclib + fulvestrant (Inavo/Pbo+Palbo+Fulv) in patients (pts) with PIK3CA-mutated, hormone receptor-positive, HER2negative locally advanced/metastatic breast cancer who relapsed during/within 12 months (mo) of adjuvant endocrine therapy completion: INAVO120 Phase III randomized trial additional analyses

Nat Rev Dis Primers 5 , 3 (2019)

J Dermatol Sci 61:162168

Pu J, Yu Y, Liu Y, Wang D, Gui S, Zhong X, et al

These medications help reduce appetite, improve satiety, and support sustainable weight loss when combined with healthy lifestyle habits